#BIO22: BIO chair Paul Hastings: 'I think people should speak their truth'
Paul Hastings doesn’t offer the usual biotech executive cliches. The ones endorsed by the media consultant crowd. And sometimes the Nkarta CEO doesn’t even wait for a question before jumping straight to his answers, his truth, as he likes to call it. And that was the way we started our conversation about his first year as chair of BIO, and how the next year is shaping up. Hastings will join our panel on managing a biotech during turbulent times, which will be available in a live setting in San Diego, or online. You can register for that — along with a lineup of virtual events — here. — John Carroll
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 144,400+ biopharma pros reading Endpoints daily — and it's free.